348 related articles for article (PubMed ID: 8640796)
1. Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer.
Gerweck LE; Seetharaman K
Cancer Res; 1996 Mar; 56(6):1194-8. PubMed ID: 8640796
[TBL] [Abstract][Full Text] [Related]
2. Tumor pH: implications for treatment and novel drug design.
Gerweck LE
Semin Radiat Oncol; 1998 Jul; 8(3):176-82. PubMed ID: 9634494
[TBL] [Abstract][Full Text] [Related]
3. Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation.
Helmlinger G; Yuan F; Dellian M; Jain RK
Nat Med; 1997 Feb; 3(2):177-82. PubMed ID: 9018236
[TBL] [Abstract][Full Text] [Related]
4. Biosensor-Enhanced Organ-on-a-Chip Models for Investigating Glioblastoma Tumor Microenvironment Dynamics.
Thenuwara G; Javed B; Singh B; Tian F
Sensors (Basel); 2024 Apr; 24(9):. PubMed ID: 38732975
[TBL] [Abstract][Full Text] [Related]
5. VISTA checkpoint inhibition by pH-selective antibody SNS-101 with optimized safety and pharmacokinetic profiles enhances PD-1 response.
Thisted T; Smith FD; Mukherjee A; Kleschenko Y; Feng F; Jiang ZG; Eitas T; Malhotra K; Biesova Z; Onumajuru A; Finley F; Cifuentes A; Zhang G; Martin GH; Takeuchi Y; Thiam K; Schreiber RD; van der Horst EH
Nat Commun; 2024 Apr; 15(1):2917. PubMed ID: 38575562
[TBL] [Abstract][Full Text] [Related]
6. Transmembrane pH gradient imaging in rodent glioma models.
Mishra SK; Santana JG; Mihailovic J; Hyder F; Coman D
NMR Biomed; 2024 May; 37(5):e5102. PubMed ID: 38263680
[TBL] [Abstract][Full Text] [Related]
7. Acid-sensing ion channels and downstream signalling in cancer cells: is there a mechanistic link?
Gründer S; Vanek J; Pissas KP
Pflugers Arch; 2024 Apr; 476(4):659-672. PubMed ID: 38175291
[TBL] [Abstract][Full Text] [Related]
8. Proximity extracellular protein-protein interaction analysis of EGFR using AirID-conjugated fragment of antigen binding.
Yamada K; Shioya R; Nishino K; Furihata H; Hijikata A; Kaneko MK; Kato Y; Shirai T; Kosako H; Sawasaki T
Nat Commun; 2023 Dec; 14(1):8301. PubMed ID: 38097606
[TBL] [Abstract][Full Text] [Related]
9. Unraveling the blue shift in porphyrin fluorescence in glioma: The 620 nm peak and its potential significance in tumor biology.
Suero Molina E; Black D; Walke A; Azemi G; D'Alessandro F; König S; Stummer W
Front Neurosci; 2023; 17():1261679. PubMed ID: 38027504
[TBL] [Abstract][Full Text] [Related]
10. Dual pH- and temperature-responsive poly(dimethylaminoethyl methacrylate)-coated mesoporous silica nanoparticles as a smart drug delivery system.
Ramezanian S; Moghaddas J; Roghani-Mamaqani H; Rezamand A
Sci Rep; 2023 Nov; 13(1):20194. PubMed ID: 37980442
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy Enhancement by Targeting Extracellular Tumor pH in Triple-Negative Breast Cancer Mouse Model.
Rahman A; Janic B; Rahman T; Singh H; Ali H; Rattan R; Kazi M; Ali MM
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894298
[TBL] [Abstract][Full Text] [Related]
12. Molecular Basis for Mambalgin-2 Interaction with Heterotrimeric α-ENaC/ASIC1a/γ-ENaC Channels in Cancer Cells.
Lyukmanova EN; Zaigraev MM; Kulbatskii DS; Isaev AB; Kukushkin ID; Bychkov ML; Shulepko MA; Chugunov AO; Kirpichnikov MP
Toxins (Basel); 2023 Oct; 15(10):. PubMed ID: 37888643
[TBL] [Abstract][Full Text] [Related]
13. Acidic extracellular pH drives accumulation of N1-acetylspermidine and recruitment of protumor neutrophils.
Kato M; Maeda K; Nakahara R; Hirose H; Kondo A; Aki S; Sugaya M; Hibino S; Nishida M; Hasegawa M; Morita H; Ando R; Tsuchida R; Yoshida M; Kodama T; Yanai H; Shimamura T; Osawa T
PNAS Nexus; 2023 Oct; 2(10):pgad306. PubMed ID: 37822765
[TBL] [Abstract][Full Text] [Related]
14. Conditionally Active, pH-Sensitive Immunoregulatory Antibodies Targeting VISTA and CTLA-4 Lead an Emerging Class of Cancer Therapeutics.
Smith FD; Pierce RH; Thisted T; van der Horst EH
Antibodies (Basel); 2023 Aug; 12(3):. PubMed ID: 37753969
[TBL] [Abstract][Full Text] [Related]
15. pH sensing at the intersection of tissue homeostasis and inflammation.
Hajjar S; Zhou X
Trends Immunol; 2023 Oct; 44(10):807-825. PubMed ID: 37714775
[TBL] [Abstract][Full Text] [Related]
16. Protons taken hostage: Dynamic H-bond networks of the pH-sensing GPR68.
Kapur B; Baldessari F; Lazaratos M; Nar H; Schnapp G; Giorgetti A; Bondar AN
Comput Struct Biotechnol J; 2023; 21():4370-4384. PubMed ID: 37711190
[TBL] [Abstract][Full Text] [Related]
17. Promoting the activity of a receptor tyrosine phosphatase with a novel pH-responsive transmembrane agonist inhibits cancer-associated phenotypes.
Rizzo S; Sikorski E; Park S; Im W; Vasquez-Montes V; Ladokhin AS; Thévenin D
Protein Sci; 2023 Sep; 32(9):e4742. PubMed ID: 37515426
[TBL] [Abstract][Full Text] [Related]
18. Association between pH regulation of the tumor microenvironment and immunological state.
Hosonuma M; Yoshimura K
Front Oncol; 2023; 13():1175563. PubMed ID: 37492477
[TBL] [Abstract][Full Text] [Related]
19. Enzyme and pH dual responsive linear-dendritic block copolymer micelles based on a phenylalanyl-lysine motif and peripherally ketal-functionalized dendron as potential drug carriers.
Wang Y; Song W; Bao L; Wei J; Qian Y; Bi Y
RSC Adv; 2023 Jul; 13(32):22079-22087. PubMed ID: 37483668
[TBL] [Abstract][Full Text] [Related]
20. Curcuminoids as Anticancer Drugs: Pleiotropic Effects, Potential for Metabolic Reprogramming and Prospects for the Future.
Pouliquen DL; Trošelj KG; Anto RJ
Pharmaceutics; 2023 May; 15(6):. PubMed ID: 37376060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
